Cogent Biosciences, Inc. (COGT) Cash Flow Statement
Cogent Biosciences, Inc. (COGT) generated -$307.5M of operating cash flow over the twelve months to 2026-06-30, spent $1.7M on capital expenditure and had free cash flow of -$309.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
COGTCogent Biosciences, Inc.Follow COGT — free
—
Price chart with a free account
- Market cap
- 5.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -32.5 | -41.5 | -35.9 | -58.8 | -118.6 | -153.6 | -207.8 | -264.4 | -307.5 | |
| Capital expenditure | 0.5 | 0.0 | — | 1.7 | 6.9 | 2.8 | 0.6 | 1.6 | -1.7 | |
| Free cash flow | -33.0 | -41.5 | — | -60.5 | -125.5 | -156.4 | -208.4 | -266.0 | -309.2 | |
| Dividends paid | — | — | 11.5 | — | — | — | — | — | — | |
| Stock-based compensation | 3.1 | 3.2 | 6.0 | 11.7 | 18.4 | 30.6 | 39.7 | 46.1 | — |
USD millions · SEC XBRL
Cogent Biosciences, Inc. — questions
- What is Cogent Biosciences, Inc.'s operating cash flow?
- -$307.5M over the twelve months to 2026-06-30.
- How much does Cogent Biosciences, Inc. spend on capital expenditure?
- $1.7M over the twelve months to 2026-06-30.
- What is Cogent Biosciences, Inc.'s free cash flow?
- -$309.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Cogent Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.